AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05133622 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Evaluation of functional strength of trunk muscles
Description: Sit-ups test: The sit-ups test is a measure the endurance of the abdominal and hip-flexor muscles. The physiotherapist will fix the feet and ask the individuals to do trunk flexion in the knee flexion position. The number of movements performed for 30 seconds will be recorded.~Push-ups test: The test will be in the prone position, with the hands at shoulder level and the elbows flexed, positioned near to the body. Individuals will raise the head, shoulders, and trunk from the ground with their elbows in full extension. The test is performed with the knees in full extension for men and modified knees in flexion for women. The number of movements performed for 30 seconds will be recorded.
Study NCT05133622 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Muscle Endurance
Description: Lateral bridge test: Lateral bridge test involves static, isometric contractions of the lateral muscles on each side of the trunk that stabilizes the spine.~Modified Biering-Sorensen test: The test measuring how many seconds the individual can keep the unsupported upper body horizontal, while placed prone with the buttocks and legs fixed to the couch by three wide canvas straps and the arms folded across the chest.~Trunk flexors endurance test: Trunk flexion test involving a static, isometric contraction of the anterior muscles, stabilizing the spine until the individual exhibits fatigue. The researcher stops the test when the individual cannot hold the assumed position.~Prone bridge test: The prone bridge test measures the muscular endurance of the abdominal muscles.
Study NCT05133622 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Flexibility
Description: Back scratch test The back-scratch test evaluates upper extremity flexibility. The individual will externally rotate one arm over her/his shoulder to reach the lowest point on the back with the palm facing the back. The other extremity reaches the highest point on the back with the palm facing forward by internal rotation of the other arm. The distance between the middle fingers of both hands will be measured with a tape measure.~Sit and reach test Sit and reach test evaluates lower extremity flexibility. In the test, a sit and reach board is used. The 0 reference point is taken as the 25 cm inner part where the feet are placed on the sit and reach the board. The part closer to the individual from the reference point shows negative values, and the part towards the far side shows positive values. Individuals will reach as far as with their fingertips by placing their feet on a sit-and-reach board.
Study NCT05133622 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Balance
Description: Single leg stance test Individuals bend one knee and place the sole on the other thigh and maintain their balance in this position. The test will be performed separately for the right and left extremities with eyes open and closed. The single-leg stance balance time was recorded as seconds (Linda,2013).~Functional reach test The functional reach test evaluates dynamic balance and limit of stability. This test measures the distance between the length of an outstretched arm in a maximal forward reach from standing while maintaining a fixed base of support. The scoring record is centimeter. Higher scores indicate a good level of balance (Lin,2012).
Study NCT05133622 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fatigue
Description: Individuals will score perceived fatigue during walking and running activities with the Modified Borg Scale. According to the scale, 0 indicates no fatigue, and a score of 10 indicates unbearable fatigue (Borg,1987).
Study NCT05327634 — intervention group
Intervention type: OTHER
Intervention: self-questionnaire
Description: Prospective study on patients aged 75 and over, hospitalised in geriatric short stay or geriatric rehabilitation units
Study NCT06102122 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: OTHER
Intervention: Compleat
Description: Patients well established and stable on a standard enteral tube feed with food derived ingredients will act as their own controls and make a product switch
Study NCT05996055 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: improved version_support device
Description: designed the NTUH version_support device based on the clinical suggestion.
Study NCT05996055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: improved version_support device
Description: designed the NTUH version_support device based on the clinical suggestion.
Study NCT05996055 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: the NTUH version_support device
Description: original designed by NTUH
Study NCT05756946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: periodontal dressing (coe-pak)
Description: Guided tissue regeneration and periodontal dressing
Study NCT05756946 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Guided Tissue Regeneration
Description: Regeneration of lost periodontal tissues
Study NCT05756946 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided Tissue Regeneration
Description: Regeneration of lost periodontal tissues
Study NCT04876365 — intervention group
Intervention type: OTHER
Intervention: Non-Interventional
Description: This is a Non-Interventional Study.
Study NCT06216678 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Healthy Dietary Pattern with Cottonseed Oil
Description: Cottonseed Oil
Study NCT06216678 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Dietary Pattern with Fatty Acid-Matched Plant Oils
Description: Plant oil blend fatty acid matched
Study NCT06216678 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Healthy Dietary Pattern with PUFA:SFA Ratio-Matched Plant Oil
Description: Plant oil with matched PUFA to SFA ratio
Study NCT05996055 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: the NTUH version_support device
Description: original designed by NTUH
Study NCT05671484 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quadratus Lumborum Plane Block
Description: Patients will receive ultrasound-guided quadratus lumborum plane block with 0,3 ml/kg of bupivacaine 0.25% just after general anesthesia induction
Study NCT05112549 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab [Opdivo]
Description: Nivolumab (OPDIVO®) is a marketed pharmaceuticals material authorized in the European Union. This study uses an off-label route of administration of nivolumab. Subjects with leptomeningeal disease in solid tumours with an approved indication for intravenous treatment with the PD1 antibody will receive an intrathecal application of nivolumab. A total of six i.th. applications will be performed every 14 days. The intrathecal administration will be performed via an Ommaya reservoir or another intraventricular catheter.
Study NCT04713124 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: R2C-M
Description: R2C-M comprises 12 modules addressing core practice elements and skills from evidence-based cognitive and behavioural interventions. Modules include: (i) self-monitoring, goal setting and behaviour change skills; (ii) identification of strengths and motivational enhancement; (iii) relapse prevention; (iv) psychoeducation and harm reduction; (v) emotion regulation skills; (vi) anger management skills; (vii) urges and cravings management skills; (viii) sleep hygiene skills; (ix) mindfulness skills; (x) interpersonal skills; (xi) anxiety management skills; (xii) depressed mood management skills. The R2C-M workbooks contain psychoeducation and intervention exercises, to facilitate counsellor-delivered exercises within sessions, and between-session practice.
Study NCT04713124 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Self-help booklet
Description: A booklet of information and self-help strategies for methamphetamine use problems.
Study NCT04713124 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Self-help booklet
Description: A booklet of information and self-help strategies for methamphetamine use problems.
Study NCT04925193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Selinexor is an oral, first-in-class, slowly reversible, potent selective inhibitor of nuclear export (SINE) compound that specifically blocks exportin 1 (XPO1).
Study NCT04925193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pomalidomide
Description: Oral Table
Study NCT06232681 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Progressive relaxation exercise
Description: The intervention group will take one month progressive relaxation exercise starting from the hospitalisation to the clinic
Study NCT05845684 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy application
Description: massage, oral and intraoral tactile stimuli and non-nutritive sucking will be performed to stimulate sucking, and massage applications and neurodevelopmental therapy for motor development.
Study NCT05845684 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control Group
Description: standard daily applications will be performed on patients
Study NCT05070598 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab +Pyrotinib + Nab-paclitaxel + Tegafur
Description: Camrelizumab was given in the first day of each cycle,Nab-paclitaxel was given in the first day of each cycle, Pyrotinib was given everyday of each cycle, Tegafur given in the day 1-14 of each cycle
Study NCT06402552 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: bp-MRI prostate
Description: Biparametric MRI is considered less comprehensive compared to multiparametric MRI (mp-MRI), which includes additional parameters like dynamic contrast-enhanced MRI (DCE-MRI). However, bp-MRI offers a simpler, faster, and often less expensive alternative that still provides critical diagnostic information, particularly in the detection of clinically significant prostate cancer. It's commonly used where less comprehensive assessment is sufficient or in situations where contrast use is contraindicated.
Study NCT06402552 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: mp-MRI prostate
Description: Multiparametric MRI is highly valued for its ability to improve the detection and characterization of clinically significant prostate cancer, aid in biopsy guidance, and help in treatment planning and monitoring. Its comprehensive approach provides crucial insights that are not as readily available through simpler imaging modalities like biparametric MRI (bp-MRI).
Study NCT05835375 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EQ-778
Description: 1. capsule daily after breakfast (in case of no URTI episode);~2. capsules after breakfast (in case of URTI episode)
Study NCT05835375 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1. capsule daily after breakfast (in case of no URTI episode);~2. capsules after breakfast (in case of URTI episode)
Study NCT05537532 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intern Health Study competition-related mobile notification
Description: Participants will receive three types of push notifications: 1. Alert of competition type (steps or sleep) and opponent (Sunday 9pm), 2. Competition score status update (Wednesday 9pm, Saturday 11am), and 3. Competition final results (Monday 12pm).
Study NCT05537532 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intern Health Study mobile app
Description: The Intern Health Study mobile app is able to conduct a daily mood survey. It also aggregates and visualizes historical data on intern mood, activity, and sleep.
Study NCT05537532 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intern Health Study mobile app competition scoreboard and history
Description: Participant can view their current competition scoreboard and competition history at any time via the study app.
Study NCT04925193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Daratumumab
Description: Injection
Study NCT04925193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carfilzomib
Description: Injection
Study NCT04925193 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Oral tablet or injection
Study NCT06037096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Attend-PE model
Description: A pulmonary embolism follow-up care model consisting of structured elements for follow-up after discharge from hospital.
Study NCT06578416 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Standardized assessments of speech and language abilities
Description: Standardized and observational assessment of speech and language abilities
Study NCT05838027 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cash Transfer
Description: Participants will receive $125 every 2 weeks for 8 payments via ClinCard, for a total of $1000.
Study NCT04983875 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: BAC-Enhanced Letter
Description: The BAC-Enhanced Letter intervention includes enhancing the standard mammography results letter with a few additional lines of text informing patients of their personal BAC status.
Study NCT04983875 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: BAC-Enhanced Letter
Description: The BAC-Enhanced Letter intervention includes enhancing the standard mammography results letter with a few additional lines of text informing patients of their personal BAC status.
Study NCT04983875 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Waitlist Control
Description: Patients randomized to this group will receive a standard post-mammography results letter which does not include any information about their personal BAC status. However, participants randomized to this group will be informed of their personal BAC findings at the end of their study participation (approximately 6 months after mammography).
Study NCT06078202 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABBV-903
Description: Tablet; oral
Study NCT05365568 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Left Bundle Branch Area Pacing (LBBAP)
Description: Left bundle branch area pacing using conventional stylet driven pacemaker leads for cardiac resynchronization therapy
Study NCT05365568 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biventricular pacing (BiV)
Description: Cardiac resynchronization therapy (CRT) using biventricular pacing (BiV)
Study NCT04580368 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CFTR Modulators
Description: Participants with rare mutations will receive active therapy in N-of-1 design with participants serving as their own control
Study NCT04694755 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: On the basis of dextrin and bitter agent, 5% of the drug was used to prepare.Its appearance, weight, color and smell are basically the same as traditional Chinese medicine granule.Tianjiang brand formula granules, in line with GMP standards
Study NCT04694755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine prescription
Description: Tianjiang brand formula granules, in line with GMP standards
Study NCT05604755 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HQP1351( Olverembatinib dimesylate)
Description: HQP1351 was initiated at a dose of 40mg every two days
Study NCT04487249 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vision Therapy
Description: 20 consecutive weeks of office-based vision therapy with home therapy that aim to improve the participant's vergence skills, accommodative skills, and sensory fusion.
Study NCT04828096 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Orthodontic retention
Description: The stability of the mandibular anterior teeth after two resp. 5 years of retention
Study NCT04828096 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Orthodontic retention
Description: The stability of the mandibular anterior teeth after two resp. 5 years of retention
Study NCT05608070 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxytocin
Description: Oxytocin 30 IU in 500 ml IV at a rate of 5 IU/h (83.33 ml/h). The infusion will be started intra-operative once the uterus is removed and will continue to run until completion of the medication or discharge from PACU criteria are met, whichever occurs first.
Study NCT05602181 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ALL Phonics Instruction
Description: The Accessible Literacy Learning (ALL) App is available in the app store and created by TobiiDynavox (an AAC device company). The ALL app is evidence informed and includes pre-made lessons in early phonics/phonological skills including: letter-sounds, sound blending, decoding, phoneme segmentation, sight words, and encoding. The materials made in the app are adapted and created for children with minimal or no speech.
Study NCT05602181 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: ALL Sight Word Instruction
Description: The Accessible Literacy Learning (ALL) App is available in the app store and created by TobiiDynavox (an AAC device company). The ALL app is evidence informed and includes pre-made lessons in early phonics/phonological skills including: letter-sounds, sound blending, decoding, phoneme segmentation, sight words, and encoding. The materials made in the app are adapted and created for children with minimal or no speech. This group will only use the sight word lessons, as well as the library for sight word books. No phonics instruction will be provided through the app.
Study NCT04682015 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: WeChat platform group
Description: Participants in the intervention group will receive educational messages related to hypertension, such as impact of hypertension on cardiovascular system, lifestyle adjustment and side effects of antihypertensive drugs. Participants will be reminded to take their blood pressure regularly and enter the blood pressure readings into the WeChat platform. If participants enter extremely high or low readings, they will be asked to seek medical help from doctors. Participants can also consult doctors online via WeChat platform by text and voice messages, or voice calls.
Study NCT05599607 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic mixture
Description: Mixture of strains of lactobacillus and bifidobacteria
Study NCT05599607 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study NCT05924698 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Electrostimulation
Description: Consisting of the use of NMES (biphasic symmetrical pulse, bipolar mode, 50Hz frequency, pulse duration 300 μs at 1:1 ratio) (S82®; Enraf-Nonius BV, Rotterdam, The Netherlands). The self-adhesive electrodes (8x5 cm2 Pals Platinum © type, Axelgaard Manufacturing Co. Ltd, Fallbrook, CA, USA) were placed on the quadriceps muscle. The positives electrodes placed distally on the rectus anterior and vastus externus and negative electrodes were placed proximally on the rectus anterior and vastus internus. The over current program consisted of 8 seconds (s) of work (ON phase) and 8 seconds of rest (OFF phase). The overcurrent program in the ON phase had a rise time of 2 s, a hold time of 4 s and a fall time of 2 s. The intensity of the electric current was increased to the maximum perceived tolerance, achieving a clear contraction without producing fatigue.
Study NCT05924698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrostimulation
Description: Consisting of the use of NMES (biphasic symmetrical pulse, bipolar mode, 50Hz frequency, pulse duration 300 μs at 1:1 ratio) (S82®; Enraf-Nonius BV, Rotterdam, The Netherlands). The self-adhesive electrodes (8x5 cm2 Pals Platinum © type, Axelgaard Manufacturing Co. Ltd, Fallbrook, CA, USA) were placed on the quadriceps muscle. The positives electrodes placed distally on the rectus anterior and vastus externus and negative electrodes were placed proximally on the rectus anterior and vastus internus. The over current program consisted of 8 seconds (s) of work (ON phase) and 8 seconds of rest (OFF phase). The overcurrent program in the ON phase had a rise time of 2 s, a hold time of 4 s and a fall time of 2 s. The intensity of the electric current was increased to the maximum perceived tolerance, achieving a clear contraction without producing fatigue.
Study NCT05924698 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Blood flow restriction therapy
Description: To attain partial vascular occlusion, a PTS ii portable tourniquet system (Delphi Medical, Vancouver, BC, Canada) with a corresponding size-specific tourniquet was placed around the patient's proximal thigh. This system allows for precise control of cuff pressure throughout training despite the changes in muscle volume that naturally occur while performing exercises. Total limb occlusion pressure (LOP) was identified by determining the pressure required to eliminate a detectable pulse using Doppler ultrasound. Partial vascular occlusion was achieved by setting the tourniquet to 80% of the LOP. This ensured that venous occlusion was obtained while still allowing arterial inflow and was personalized to each patient despite variations in thigh girth, cuff size, and systolic blood pressure. An Easy-Fit Tourniquet Cuff (Delfi Medical, Vancouver, VC, Canada) was used with the PTS ii system.
Study NCT05608070 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% saline infusion at the rate of 83.3 ml/h.